司美匹韦

司美匹韦性质、用途与生产工艺

生物活性

Simeprevir (TMC-435, TMC-435350) 一种竞争性的、可逆的、非共价结合的大环hepatitis C virus (HCV) NS3/4A protease抑制剂，直接抑制HCV病毒。它对HCV NS3/4A(genotypes 1a, 1b, 2, 4, 5, and 6)的平均IC50值小于13 nM，而对genotype 3的IC50值为37 nM。

靶点

Target	Value
HCV NS3/4A protease ()

司美匹韦 上下游产品信息

上游原料

下游产品

司美匹韦 试剂级价格

更新日期	产品编号	产品名称	CAS编号	包装	价格
2025/09/19	S5015	司美匹韦 Simeprevir	923604-59-5	5mg	1040.41元
2025/09/19	S5015	司美匹韦 Simeprevir	923604-59-5	25mg	3195.07元

司美匹韦 生产厂家

 

923604-59-5, 司美匹韦 相关搜索:

• API
• FDA批准的配体
• 化学试剂
• 原料药及中间体
• 医药原料药
• 代谢
• 医药原料
• 化学原药
• 抑制剂
• C38H47N5O7S2
• 西咪匹韦,10 MM DMSO 溶液
• (2R,3AR,11AS,12AR,14AR,Z)-N-(环丙基磺酰基)-2-((2-(4-异丙基噻唑-2-基)-7-甲氧基-8-甲基喹啉-4-基)氧基)-5-甲基-4,14-二氧代-2,3,3A,4,5,6,7,8,9,11A,12,13,14,14A-十四氢环戊二烯并[C]环丙并[G][1,6]二氮杂环十四
• 西咪匹韦-[13C, D3]/精确称量
• (2R,3AR,11AS,12AR,14AR,Z)-N-(环丙基磺酰基)-2-((2-(4-异丙基噻唑-2-基)-7-甲氧基-8-甲基喹啉-4-基)氧基)-5-甲基-4,14-二氧代-2,3,3A,4,5,6,7,8,9,11A,12,13,14,14A-十四氢环戊二烯并[C]环丙并[G][1,6]二氮杂环十四烯-12A(1H)-甲酰胺
• 司美匹韦,西米普韦
• 8-甲基-2-[4-(1-甲基乙基)-2-噻唑基]-4-喹啉基]氧基]-5-甲基-4,14-二氧代环戊并[C]环丙并[G][1,6]二氮杂环十四烯-12A(1H)-甲酰胺/(2R,3AR,10Z,11AS,12AR,14AR)-N-(环丙基磺酰基)-2,3,3A,4,5,6,7,8,9,11A,12,13,14,14A-十四氢-2-[[7-甲氧基-8-甲基-2-[4-(1-甲基乙基)-2-噻唑基]-4-喹啉基]氧基]-5-甲基-4,14-二氧代环戊并[C]环丙并[G][1,6]二氮杂环十四烯-12A(1H)-甲酰胺/司美匹韦/西米普韦/希普瑞为/西美瑞韦
• 西咪匹韦-[13C, D3]
• 希普瑞为/司美匹韦西米普韦/希普瑞为/西咪匹韦
• SIMEPREVIR (SODIUM SALT)
• 西咪匹韦杂质
• 8-甲基-2-[4-(1-甲基乙基)-2-噻唑基]-4-喹啉基]氧基]-5-甲基-4,14-二氧代环戊并[C]环丙并[G][1,6]二氮杂环十四烯-12A(1H)-甲酰胺
• 西米普韦
• 8-甲基-2-[4-(1-甲基乙基)-2-噻唑基]-4-喹啉基]氧基]-5-甲基-4,14-二氧代环戊并[C]环丙并[G][1,6]二氮杂环十四烯-12A(1H
• 司美匹韦
• 司美匹韦 5MG
• 西美瑞韦
• 西米普韦 别名: TMC 435350
• 希普瑞为
• 申米普韦
• 西咪匹韦
• 西米皮韦
• (2R,3AR,10Z,11AS,12AR,14AR)-N-(环丙基磺酰基)-2,3,3A,4,5,6,7,8,9,11A,12,13,14,14A-十四氢-2-[[7-甲氧基-8-甲基-2-[4-(1-甲基乙基)-2-噻唑基]-4-喹啉基]氧基]-5-甲基-4,14-二氧代环戊并[C]环丙并[G][1,6]二氮杂环十四烯-12A(1H)-甲酰胺
• 923604-59-5
• Simeprevir, 10 mM in DMSO
• (2R,3aR,11aS,12aR,14aR,Z)-N-(Cyclopropylsulfonyl)-2-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)-5-methyl-4,14-dioxo-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydrocyclopenta[
• (2R,3aR,11aS,12aR,14aR,Z)-N-(Cyclopropylsulfonyl)-2-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)-5-methyl-4,14-dioxo-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxamide
• (1R,4R,6S,15R,17R)-N-(cyclopropanesulfonyl)-17-({7-methoxy-8-methyl-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)-13-methyl-2,14-dioxo-3,13-diazatricyclo[13.3.0.0,4,6]octadec-7-ene-4-carboxamide
• Simeprevir (1.0mg/ml in DMSO)
• Cyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxamide, N-(cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxo-, (2R,3aR,10Z,11aS,12aR,14aR)-
• (2R,3aR,11aS,12aR,14aR,Z)-N-(cyclopropylsulfonyl)-2-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)-5-methyl-4,14-dioxo-1,2,3,3a,4,5,6,7,8,9,11a,12,12a,13,14,14a-hexadecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a-carboxamide
• Simeprevir (sodium salt)
• Simeprevir-13C-d3
• PubChem ID: 24873435
• TMC435350 (Simeprevir)
• CS-954
• (2R,3aR,11aS,12aR,14aR,Z)-N-(cyclopropylsulfonyl)-2-((2-(4-isopropylthiazol-2-yl)-7-methoxy-8-methylquinolin-4-yl)oxy)-5-methyl-4,14-dioxo-1,2,3,3a,4,5,6,7,8,9,11a,12,12a,13,14,14a-hexadecahydrocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a-carb
• JTZZSQYMACOLNN-JMSVMWJJSA-N
• (2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxocyclopenta[c]cyclopropa[g][1,6]diazacyclotetrad
• (2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-7-methoxy-8-methyl-2-4-(1-methylethyl)-2-thiazolyl-4-quinolinyloxy-5-methyl-4,14-dioxocyclopentaccyclopropag1,6diazacyclotetradecine-12a(1H)-carboxami
• TMC435
• Simeprevir(TMC 435350)
• (2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-Methoxy-8-Methyl-2-[4-(1-Methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-Methyl-4,14-dioxocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1
• siMeprevir/TMC435
• (2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13, 14,14a-tetradecahydro-2-[[7-
• TMC435,TMC435350,TMC-435350
• SiMeprevir
• TMC 435350
• (2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxamide